Glaukos Corporation
Glaukos Corporation (GKOS) Financial Performance & Income Statement Overview
Analyze Glaukos Corporation (GKOS) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Glaukos Corporation (GKOS) Income Statement & Financial Overview
Explore comprehensive income reports for Glaukos Corporation GKOS, broken down by year and quarter.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $106.66M | $105.50M | $96.67M | $95.69M |
| Cost of Revenue | $24.32M | $28.64M | $22.58M | $22.55M |
| Gross Profit | $82.35M | $76.86M | $74.09M | $73.14M |
| Gross Profit Ratio | $0.77 | $0.73 | $0.77 | $0.76 |
| R&D Expenses | $32.35M | $36.53M | $34.75M | $34.43M |
| SG&A Expenses | $70.67M | $69.003M | $64.00M | $66.19M |
| Operating Expenses | $103.03M | $105.53M | $98.75M | $100.61M |
| Total Costs & Expenses | $127.34M | $134.16M | $121.33M | $123.16M |
| Interest Income | $3.08M | $2.49M | $2.70M | $2.83M |
| Interest Expense | $1.16M | $1.57M | $1.66M | $3.35M |
| Depreciation & Amortization | -$1.70M | $9.82M | $9.00M | $7.93M |
| EBITDA | -$20.68M | -$19.11M | -$10.57M | -$29.97M |
| EBITDA Ratio | -$0.19 | -$0.18 | -$0.11 | -$0.31 |
| Operating Income | -$20.68M | -$28.67M | -$24.66M | -$27.47M |
| Operating Income Ratio | -$0.19 | -$0.27 | -$0.26 | -$0.29 |
| Other Income/Expenses (Net) | $2.86M | -$5.03M | $3.43M | -$20.24M |
| Income Before Tax | -$17.82M | -$33.69M | -$21.23M | -$50.21M |
| Income Before Tax Ratio | -$0.17 | -$0.32 | -$0.22 | -$0.52 |
| Income Tax Expense | $326000.00 | -$114000.00 | $177000.00 | $331000.00 |
| Net Income | -$18.15M | -$33.58M | -$21.41M | -$50.55M |
| Net Income Ratio | -$0.17 | -$0.32 | -$0.22 | -$0.53 |
| EPS | -$0.32 | -$0.60 | -$0.39 | -$1.00 |
| Diluted EPS | -$0.32 | -$0.60 | -$0.39 | -$1.00 |
| Weighted Avg Shares Outstanding | $56.64M | $55.58M | $55.04M | $50.72M |
| Weighted Avg Shares Outstanding (Diluted) | $56.64M | $55.58M | $55.04M | $50.72M |
Over the past four quarters, Glaukos Corporation demonstrated steady revenue growth, increasing from $95.69M in Q2 2024 to $106.66M in Q1 2025. Operating income reached -$20.68M in Q1 2025, maintaining a consistent -19% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$20.68M, reflecting operational efficiency. Net income rose to -$18.15M, with EPS at -$0.32. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan